APOGEE THERAPEUTICS INC (APGE) Forecast, Price Target & Analyst Ratings

NASDAQ:APGE • US03770N1019

Current stock price

88.47 USD
+1.73 (+1.99%)
At close:
88.71 USD
+0.24 (+0.27%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APOGEE THERAPEUTICS INC (APGE).

Forecast Snapshot

Consensus Price Target

Price Target
$119.20
+ 34.74% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$1.12
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$119.20
Upside
+ 34.74%
From current price of $88.47 to mean target of $119.20, Based on 23 analyst forecasts
Low
$82.82
Median
$120.36
High
$168.00

Price Target Revisions

1 Month
12.06%
3 Months
19.86%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for APGE. The average price target is 119.2 USD. This implies a price increase of 34.74% is expected in the next year compared to the current price of 88.47.
The average price target has been revised upward by 19.86% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

APGE Current Analyst RatingAPGE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

APGE Historical Analyst RatingsAPGE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
85.22%
APGE was analyzed by 23 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about APGE.
In the previous month the buy percentage consensus was at a similar level.
APGE was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-30MizuhoMaintains Outperform -> Outperform
2026-03-24GuggenheimMaintains Buy -> Buy
2026-03-24Canaccord GenuityMaintains Buy -> Buy
2026-03-24CitigroupMaintains Buy -> Buy
2026-03-23BTIGReiterate Buy -> Buy
2026-03-18Truist SecuritiesInitiate Hold
2026-03-16BTIGReiterate Buy -> Buy
2026-03-03RBC CapitalMaintains Sector Perform -> Sector Perform
2026-03-03WedbushMaintains Outperform -> Outperform
2026-01-22RBC CapitalDowngrade Outperform -> Sector Perform
2026-01-07Wolfe ResearchInitiate Peer Perform
2026-01-06BTIGMaintains Buy -> Buy
2026-01-05BTIGMaintains Buy -> Buy
2025-12-17Stephens & Co.Initiate Overweight
2025-12-10Deutsche BankInitiate Buy
2025-11-03RBC CapitalMaintains Outperform -> Outperform
2025-11-03Craig-HallumInitiate Buy
2025-10-21MizuhoInitiate Outperform
2025-10-09BTIGReiterate Buy -> Buy
2025-09-25RBC CapitalInitiate Outperform
2025-08-28B of A SecuritiesMaintains Buy -> Buy
2025-07-02GuggenheimReiterate Buy -> Buy
2025-03-13CitigroupInitiate Buy
2025-02-10GuggenheimReiterate Buy -> Buy
2024-12-12GuggenheimReiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$1.12
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-18.41%
Number of Analysts
18

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
1.56%
EPS (3 Months)
-1.47%

Next Earnings Summary

APGE is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -1.12 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
APGE revenue by date.APGE revenue by date.
N/AN/AN/AN/A
4,138.17%		N/A
304.95%		N/A
99.08%		N/A
71.11%		N/A
39.28%
EBITDA
YoY % growth
APGE ebitda by date.APGE ebitda by date.
N/AN/A-216.681M-284.177M
-31.15%		N/A
-29.39%		N/A
-13.21%		N/A
-14.63%		N/A
30.00%		N/AN/AN/AN/A
EBIT
YoY % growth
APGE ebit by date.APGE ebit by date.
-30.727M-93.003M
-202.68%		-216.87M
-133.19%		-285.595M
-31.69%		N/A
-24.09%		N/A
-21.34%		N/A
-25.47%		N/A
2.06%		N/A
59.60%		N/A
350.66%		N/A
167.59%		N/A
29.33%
Operating Margin
APGE operating margin by date.APGE operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
APGE eps by date.APGE eps by date.
N/AN/A-3.29
-18.55%		-4.22
-28.38%		N/A
-14.98%		N/A
-18.59%		N/A
-17.85%		N/A
27.56%		N/A
51.21%		N/A
266.10%		N/A
176.77%		N/A
58.41%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-1.12
-18.41%		-1.19
-4.89%		-1.23
-10.81%		-1.33
-29.04%		-1.24
-10.66%		-1.26
-6.37%		-1.30
-5.54%		-1.37
-2.96%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-82.646M
-31.42%		-91.479M
-26.08%		-94.074M
-33.88%		-104.651M
-36.55%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-80.983M
-28.35%		-85.975M
-17.51%		-89.604M
-25.71%		-96.883M
-24.12%		-94.503M
-16.69%		-96.492M
-12.23%		-97.869M
-9.22%		-100.827M
-4.07%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

APGE Yearly Revenue VS EstimatesAPGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B
APGE Yearly EPS VS EstimatesAPGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-17.13%
EPS Next 5 Year
7.45%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-18.47%
EBIT Next 5 Year
-3.87%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

APOGEE THERAPEUTICS INC / APGE Forecast FAQ

What is the average price target for APOGEE THERAPEUTICS INC (APGE) stock?

23 analysts have analysed APGE and the average price target is 119.2 USD. This implies a price increase of 34.74% is expected in the next year compared to the current price of 88.47.

When does APOGEE THERAPEUTICS INC (APGE) report earnings?

APOGEE THERAPEUTICS INC (APGE) will report earnings on 2026-05-11.

What are the consensus estimates for APGE stock next earnings?

The consensus EPS estimate for the next earnings of APOGEE THERAPEUTICS INC (APGE) is -1.12 USD and the consensus revenue estimate is 0 USD.